{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:22:51Z","timestamp":1794057771472,"version":"4.8.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recurrence and biochemical remission rates vary widely among different histological subtypes of pituitary adenoma. In this prospective study, we evaluated 107 consecutive primary pituitary adenomas operated on by a single neurosurgeon including 28 corticotroph, 27 gonadotroph, 24 somatotroph, 17 lactotroph, 5 null-cell and 6 plurihormonal. In each case, we performed direct endoscopic intraoperative inspection of the medial wall of the cavernous sinus, which was surgically removed when invasion was visualized. This was performed irrespective of tumor functional status. Medial wall resection was performed in 47% of pituitary adenomas, and 39\/50 walls confirmed pathologic evidence of invasion, rendering a positive predictive value of intraoperative evaluation of medial wall invasion of 78%. We show for the first-time dramatic disparities in the frequency of medial wall invasion among pathological subtypes. Somatotroph tumors invaded the medial wall much more often than other adenoma subtypes, 81% intraoperatively and 69% histologically, followed by plurihormonal tumors (40%) and gonadotroph cell tumors (33%), both with intraoperative positive predictive value of 100%. The least likely to invade were corticotroph adenomas, at a rate of 32% intraoperatively and 21% histologically, and null-cell adenomas at 0%. Removal of the cavernous sinus medial wall was not associated with permanent cranial nerve morbidity nor carotid artery injury, although 4 patients (all Knosp 3-4) experienced transient diplopia. Medial wall resection in acromegaly resulted in the highest potential for biochemical remission ever reported, with an average postoperative day 1 GH levels of 0.96 ug\/L and surgical remission rates of 92% based on normalization of IGF-1 levels after surgery (mean = 15.56 months; range 3\u201330 months). Our findings suggest that tumor invasion of the medial wall of the cavernous sinus may explain the relatively low biochemical remission rates currently seen for acromegaly and illustrate the relevance of advanced intradural surgical approaches for successful and durable outcomes in endonasal pituitary surgery for functional adenomas.<\/jats:p>","DOI":"10.1038\/s41598-022-12980-1","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T06:03:06Z","timestamp":1655272986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes"],"prefix":"10.1038","volume":"12","author":[{"given":"Ahmed","family":"Mohyeldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence J.","family":"Katznelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam","family":"Asmaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman S.","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Eltobgy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayakar V.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Fernandez-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"12980_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes, M. B. S. The 2017 world health organization classification of tumors of the pituitary gland: a summary. Acta. Neuropathol. 134, 521\u201335 (2017).","journal-title":"Acta. Neuropathol."},{"key":"12980_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed, S. Pituitary-tumor endocrinopathies. N. Engl. J. Med. 382, 937\u201350 (2020).","journal-title":"N. Engl. J. Med."},{"key":"12980_CR3","unstructured":"WHO classification of tumours of endocrine organs, 4th edn. Lyon, France: IARC Press 2017."},{"key":"12980_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3171\/2011.8.JNS11456","volume":"116","author":"RR Lonser","year":"2012","unstructured":"Lonser, R. R., Ksendzovsky, A., Wind, J. J., Vortmeyer, A. O. & Oldfield, E. H. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease. J. Neurosurg. 116, 272\u20139 (2012).","journal-title":"J. Neurosurg."},{"key":"12980_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"AS Micko","year":"2015","unstructured":"Micko, A. S., Wohrer, A., Wolfsberger, S. & Knosp, E. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J. Neurosurg. 122, 803\u201311 (2015).","journal-title":"J. Neurosurg."},{"key":"12980_CR6","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3171\/2019.3.JNS19367","volume":"132","author":"A Micko","year":"2019","unstructured":"Micko, A. et al. Challenging Knosp high-grade pituitary adenomas. J. Neurosurg. 132, 1739\u201346 (2019).","journal-title":"J. Neurosurg."},{"key":"12980_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3171\/jns.1986.65.6.0733","volume":"65","author":"BW Scheithauer","year":"1986","unstructured":"Scheithauer, B. W., Kovacs, K. T., Laws, E. R. Jr. & Randall, R. V. Pathology of invasive pituitary tumors with special reference to functional classification. J. Neurosurg. 65, 733\u201344 (1986).","journal-title":"J. Neurosurg."},{"key":"12980_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000371806","volume":"101","author":"E Chatzellis","year":"2015","unstructured":"Chatzellis, E., Alexandraki, K. I., Androulakis, I. I. & Kaltsas, G. Aggressive pituitary tumors. Neuroendocrinology 101, 87\u2013104 (2015).","journal-title":"Neuroendocrinology"},{"key":"12980_CR9","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2010.7.FOCUS10155","volume":"29","author":"G Zada","year":"2010","unstructured":"Zada, G., Lin, N. & Laws, E. R. Jr. Patterns of extrasellar extension in growth hormone-secreting and nonfunctional pituitary macroadenomas. Neurosurg. Focus 29, E4 (2010).","journal-title":"Neurosurg. Focus"},{"issue":"123\u201334","key":"12980_CR10","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou, M. et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37(123\u201334), e5 (2020).","journal-title":"Cancer Cell"},{"key":"12980_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1227\/01.NEU.0000126953.59406.77","volume":"55","author":"A Yasuda","year":"2004","unstructured":"Yasuda, A., Campero, A., Martins, C., Rhoton, A. L. Jr. & Ribas, G. C. The medial wall of the cavernous sinus: Microsurgical anatomy. Neurosurgery 55, 179\u201389 (2004).","journal-title":"Neurosurgery"},{"key":"12980_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3171\/2018.3.JNS18596","volume":"131","author":"HQ Truong","year":"2018","unstructured":"Truong, H. Q. et al. The medial wall of the cavernous sinus. Part 1: Surgical anatomy, ligaments, and surgical technique for its mobilization and\/or resection. J. Neurosurg. 131, 122\u201330 (2018).","journal-title":"J. Neurosurg."},{"key":"12980_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3171\/2018.5.JNS18595","volume":"131","author":"S Cohen-Cohen","year":"2018","unstructured":"Cohen-Cohen, S. et al. The medial wall of the cavernous sinus. Part 2: Selective medial wall resection in 50 pituitary adenoma patients. J. Neurosurg. 131, 131\u201340 (2018).","journal-title":"J. Neurosurg."},{"key":"12980_CR14","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1210\/jc.2013-1036","volume":"98","author":"RM Starke","year":"2013","unstructured":"Starke, R. M. et al. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J. Clin. Endocrinol. Metab. 98, 3190\u20138 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"12980_CR15","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s11102-020-01063-x","volume":"23","author":"N Agrawal","year":"2020","unstructured":"Agrawal, N. & Ioachimescu, A. G. Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: A structured review. Pituitary 23, 582\u201394 (2020).","journal-title":"Pituitary"},{"key":"12980_CR16","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp, E., Steiner, E., Kitz, K. & Matula, C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33, 610\u20137 (1993).","journal-title":"Neurosurgery"},{"key":"12980_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3171\/jns.1986.64.3.0402","volume":"64","author":"WR Selman","year":"1986","unstructured":"Selman, W. R., Laws, E. R. Jr., Scheithauer, B. W. & Carpenter, S. M. The occurrence of dural invasion in pituitary adenomas. J. Neurosurg. 64, 402\u20137 (1986).","journal-title":"J. Neurosurg."},{"key":"12980_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00006123-199601000-00024","volume":"38","author":"K Thapar","year":"1996","unstructured":"Thapar, K. et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody. Neurosurgery 38, 99\u2013106 (1996).","journal-title":"Neurosurgery"},{"key":"12980_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/neuros\/nyx378","volume":"64","author":"EH Oldfield","year":"2017","unstructured":"Oldfield, E. H. Cushing\u2019s disease: Lessons learned from 1500 cases. Neurosurgery 64, 27\u201336 (2017).","journal-title":"Neurosurgery"},{"key":"12980_CR20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3171\/jns.2002.97.6.1343","volume":"97","author":"RD Dickerman","year":"2002","unstructured":"Dickerman, R. D. & Oldfield, E. H. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J. Neurosurg. 97, 1343\u20139 (2002).","journal-title":"J. Neurosurg."},{"key":"12980_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/2014.3.JNS132214","volume":"121","author":"H Nishioka","year":"2014","unstructured":"Nishioka, H., Fukuhara, N., Horiguchi, K. & Yamada, S. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes. J. Neurosurg. 121, 505\u201310 (2014).","journal-title":"J. Neurosurg."},{"key":"12980_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.wneu.2019.02.134","volume":"126","author":"Y Nagata","year":"2019","unstructured":"Nagata, Y. et al. Removal of the medial wall of the cavernous sinus for functional pituitary adenomas: A technical report and pathologic significance. World Neurosurg. 126, 53\u20138 (2019).","journal-title":"World Neurosurg."},{"key":"12980_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/jns.2002.96.2.0195","volume":"96","author":"BP Meij","year":"2002","unstructured":"Meij, B. P., Lopes, M. B., Ellegala, D. B., Alden, T. D. & Laws, E. R. Jr. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J. Neurosurg. 96, 195\u2013208 (2002).","journal-title":"J. Neurosurg."},{"key":"12980_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1055\/s-0037-1603649","volume":"78","author":"MA Mooney","year":"2017","unstructured":"Mooney, M. A. et al. Rater reliability of the hardy classification for pituitary adenomas in the magnetic resonance imaging era. J. Neurol. Surg. B Skull Base 78, 413\u20138 (2017).","journal-title":"J. Neurol. Surg. B Skull Base"},{"issue":"6","key":"12980_CR25","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3171\/2019.3.JNS19367","volume":"132","author":"A Micko","year":"2019","unstructured":"Micko, A. et al. Challenging Knosp high-grade pituitary adenomas. J. Neurosurg. 132(6), 1739\u20131746 (2019).","journal-title":"J. Neurosurg."},{"key":"12980_CR26","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina, A. et al. A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141\u20138 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"12980_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.687333","volume":"11","author":"X Cai","year":"2021","unstructured":"Cai, X. et al. A nomogram for preoperatively predicting the Ki-67 index of a pituitary tumor: A retrospective cohort study. Front. Oncol. 11, 687333 (2021).","journal-title":"Front. Oncol."},{"key":"12980_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3346\/jkms.2005.20.3.489","volume":"20","author":"KI Paek","year":"2005","unstructured":"Paek, K. I. et al. Clinical significance of Ki-67 labeling index in pituitary macroadenoma. J. Korean Med. Sci. 20, 489\u201394 (2005).","journal-title":"J. Korean Med. Sci."},{"key":"12980_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00701-019-03879-4","volume":"161","author":"F Grimm","year":"2019","unstructured":"Grimm, F. et al. Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas. Acta Neurochir. (Wien) 161, 1149\u201356 (2019).","journal-title":"Acta Neurochir. (Wien)"},{"key":"12980_CR30","doi-asserted-by":"crossref","unstructured":"Yuhan, L., Zhiqun, W., Jihui, T., Renlong, P. Ki-67 labeling index and Knosp classification of pituitary adenomas. Br. J. Neurosurg.1-5 (2021).","DOI":"10.1080\/02688697.2021.1884186"},{"key":"12980_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3171\/2017.2.JNS162673","volume":"129","author":"JP Almeida","year":"2018","unstructured":"Almeida, J. P. et al. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. J. Neurosurg. 129, 404\u201316 (2018).","journal-title":"J. Neurosurg."},{"key":"12980_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41591-019-0715-9","volume":"26","author":"TC Hollon","year":"2020","unstructured":"Hollon, T. C. et al. Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks. Nat. Med. 26, 52\u20138 (2020).","journal-title":"Nat. Med."},{"key":"12980_CR33","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00701-016-2903-4","volume":"158","author":"D Starnoni","year":"2016","unstructured":"Starnoni, D. et al. Surgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis. Acta Neurochir. (Wien) 158, 2109\u201321 (2016).","journal-title":"Acta Neurochir. (Wien)"},{"key":"12980_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3171\/2014.3.JNS132214","volume":"121","author":"H Nishioka","year":"2014","unstructured":"Nishioka, H. & Yamada, S. Response. J. Neurosurg. 121, 503\u20134 (2014).","journal-title":"J. Neurosurg."},{"key":"12980_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1530\/eje.1.01863","volume":"152","author":"P Nomikos","year":"2005","unstructured":"Nomikos, P., Buchfelder, M. & Fahlbusch, R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u201ccure\u201d. Eur. J. Endocrinol. 152, 379\u201387 (2005).","journal-title":"Eur. J. Endocrinol."},{"key":"12980_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11102-007-0072-4","volume":"11","author":"ZB Wu","year":"2008","unstructured":"Wu, Z. B. et al. Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion. Pituitary 11, 63\u201370 (2008).","journal-title":"Pituitary"},{"key":"12980_CR37","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/neuonc\/noz225","volume":"22","author":"R Kotecha","year":"2020","unstructured":"Kotecha, R. et al. Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and international stereotactic radiosurgery society practice opinion. Neuro. Oncol. 22, 318\u201332 (2020).","journal-title":"Neuro. Oncol."},{"key":"12980_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11060-017-2520-y","volume":"135","author":"O Cohen-Inbar","year":"2017","unstructured":"Cohen-Inbar, O. et al. Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study. J. Neurooncol. 135, 67\u201374 (2017).","journal-title":"J. Neurooncol."},{"key":"12980_CR39","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ijrobp.2014.07.013","volume":"90","author":"Z Xu","year":"2014","unstructured":"Xu, Z. et al. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study. Int. J. Radiat. Oncol. Biol. Phys. 90, 903\u201310 (2014).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"12980_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/neuros\/nyy178","volume":"84","author":"D Ding","year":"2019","unstructured":"Ding, D. et al. Stereotactic radiosurgery for acromegaly: An international multicenter retrospective cohort study. Neurosurgery 84, 717\u201325 (2019).","journal-title":"Neurosurgery"},{"key":"12980_CR41","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1016\/j.wneu.2019.01.252","volume":"125","author":"A Shrivastava","year":"2019","unstructured":"Shrivastava, A. et al. Outcomes after gamma knife stereotactic radiosurgery in pediatric patients with cushing disease or acromegaly: A multi-institutional study. World Neurosurg. 125, e1104\u2013e13 (2019).","journal-title":"World Neurosurg."},{"key":"12980_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/342034","volume":"2012","author":"A Franzin","year":"2012","unstructured":"Franzin, A., Spatola, G., Losa, M., Picozzi, P. & Mortini, P. Results of gamma knife radiosurgery in acromegaly. Int. J. Endocrinol. 2012, 342034 (2012).","journal-title":"Int. J. Endocrinol."},{"key":"12980_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11060-012-0862-z","volume":"109","author":"X Liu","year":"2012","unstructured":"Liu, X. et al. Gamma knife radiosurgery for clinically persistent acromegaly. J. Neurooncol. 109, 71\u20139 (2012).","journal-title":"J. Neurooncol."},{"key":"12980_CR44","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3171\/2019.1.JNS183398","volume":"132","author":"N Mohammed","year":"2019","unstructured":"Mohammed, N. et al. Primary versus postoperative stereotactic radiosurgery for acromegaly: A multicenter matched cohort study. J. Neurosurg. 132, 1507\u201316 (2019).","journal-title":"J. Neurosurg."},{"key":"12980_CR45","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1210\/jc.2008-0135","volume":"93","author":"M Losa","year":"2008","unstructured":"Losa, M. et al. The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J. Clin. Endocrinol. Metab. 93, 2546\u201352 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"12980_CR46","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1210\/jc.2005-0311","volume":"90","author":"F Castinetti","year":"2005","unstructured":"Castinetti, F. et al. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: Correlation with initial hypersecretion. J. Clin. Endocrinol. Metab. 90, 4483\u20138 (2005).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12980-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12980-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12980-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:19:57Z","timestamp":1669335597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12980-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12980"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12980-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"18 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9919"}}